SMITH & NEPHEW

Research SMITH & NEPHEW (NPW1) on Bullrun: P/E 27.6, dividend yield 2.7%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

P/E is 27.6; dividend yield is 2.7%.

Peer valuation comparison

Latest P/E is 27.63x versus a United Kingdom median of 16.18x (70.8% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 6.16BUSD 625.00MUSD 852.00M68.0%0.72USD 557.00MUSD 3.33BUSD 5.29B
FY2024USD 5.81BUSD 412.00MUSD 606.00M69.6%0.47USD 619.00MUSD 3.32BUSD 5.27B
FY2023USD 5.55BUSD 263.00MUSD 181.00M68.8%0.3USD 302.00MUSD 3.08BUSD 5.22B
FY2022USD 5.22BUSD 223.00MUSD 110.00M70.5%0.25USD 350.00MUSD 2.87BUSD 5.26B
FY2021USD 5.21BUSD 524.00Mn/a70.4%0.6USD 1.29Bn/aUSD 5.57B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-23n/a27.6n/a0.4

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.4 EUR, yield 2.7%.

YearDividends/share
FY20250.33 USD
FY20240.32 USD
FY20230.32 USD
FY20220.32 USD
FY20210.32 USD

About SMITH & NEPHEW

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures;

Related stock research

United Kingdom stocks A-Z stock index

Other related stocks

Keller Group plc (01K) The Artisanal Spirits Company plc (045) Ferrari Group PLC (046) Time Out Group plc (05T) ADVANCEDADVT LTD. ORD NPV (06P0) International Consolidated Airlines Group S.A. (0A2L) Card Factory PLC (0CT) CORAL PRODUCTS LS-01 (0EN) WICKES GROUP PLC LS-10 (0FD) HENRY BOOT PLC LS-10 (0KH) SEVERFIELD PLC LS -025 (0L3) Nomad Foods Limited (0NH)

Frequently asked questions

What is SMITH & NEPHEW's P/E ratio?

SMITH & NEPHEW's price-to-earnings (P/E) ratio is 27.6.

Does SMITH & NEPHEW pay a dividend?

SMITH & NEPHEW has a dividend yield of 2.7%.

What does SMITH & NEPHEW do?

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.